Back

Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy

20 May 2023 (15:00 - 15:10)
Organised by: Logo
Congress Presentation Part of: Cardiomyopathy: from bench to bedside Clinical HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Aldostefano Porcari

Royal Free London NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Impact of sex on outcome in patients with genetic dilated cardiomyopathy
Mr J. Verdonschot (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Incidence and clinical outcomes of fulminant myocarditis related with Covid-19 vaccination
Professor K. Kim (Gwangju, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathy: from bench to bedside
Video

The Event

Event poster

Heart Failure 2023

20 May 2023 15:00 CET
You may be interested in
thumbnail
Congress Session
Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment
thumbnail
Congress Presentation
International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction
thumbnail
Congress Session
The evolving landscape of transthyretin amyloidosis